Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor.

Authors: Pasteris, NG  Cadle, A  Logie, LJ  Porteous, ME  Schwartz, CE  Stevenson, RE  Glover, TW  Wilroy, RS  Gorski, JL 
Citation: Pasteris NG, etal., Cell. 1994 Nov 18;79(4):669-78.
Pubmed: (View Article at PubMed) PMID:7954831

Faciogenital dysplasia (FGDY), also known as Aarskog-Scott syndrome, is an X-linked developmental disorder characterized by disproportionately short stature and by facial, skeletal, and urogenital anomalies. Molecular genetic analyses mapped FGDY to chromosome Xp11.21. To clone this gene, YAC clones spanning an FGDY-specific translocation breakpoint were isolated. An isolated cDNA, FGD1, is disrupted by the breakpoint, and FGD1 mutations cosegregate with the disease. FGD1 codes for a 961 amino acid protein that has strong homology to Rho/Rac guanine nucleotide exchange factors (GEFs), contains a cysteine-rich zinc finger-like region, and, like the RasGEF mSos, contains two potential SH3-binding sites. These results provide compelling evidence that FGD1 is responsible for FGDY and suggest that FGD1 is a Rho/RacGEF involved in mammalian development.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11554024
Created: 2016-10-19
Species: All species
Last Modified: 2016-10-19
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.